신생아 전용 말라리아 치료제 WHO 승인의 획기적 이정표
Landmark WHO Approval for First Newborn-Specific Malaria Drug
AllAfrica
· 🇿🇦 Cape Town, ZA
EN
2026-04-28 22:50
Translated
세계보건기구(WHO)는 신생아와 매우 어린 영아를 위해 독점적으로 개발된 첫 번째 말라리아 치료제를 승인했다. 4월 24일 발표된 이번 승인은 해당 치료제가 국제 안전성 및 효과성 기준을 충족함을 확인해준다.
테드로스 아다놈 게브레예수스 WHO 사무총장은 질병 퇴치 과정에서 이루어진 진전을 찬양했다: "수세기 동안 말라리아는 부모들로부터 자녀들을 빼앗았으며, 지역사회로부터 건강, 부, 희망을 앗아갔다". WHO 사무총장은 새로운 백신, 진단 검사, 차세대 모기장도 상황을 반전시키는 데 도움이 되고 있다고 덧붙였다.
새로운 아르테메터-루메팬트린 제제는 PAMAfrica 컨소시엄 산하에서 노바티스와 말라리아약물벤처(MMV) 간의 파트너십을 통해 개발되었다. 2025년 8월, 아프리카질병통제예방센터(Africa CDC)는 스위스 의약품 규제기관의 제제 승인을 칭찬하면서 임상시험에 참여한 8개 아프리카 국가를 칭송했다.
예방 가능한 도구에도 불구하고 아프리카에서는 감염 사례가 증가하고 있으며, 2030년 유엔 소멸 목표 달성을 위한 긴급한 글로벌 촉구가 이루어지고 있다. 말라리아는 전 세계적으로 계속해서 수천 명의 생명을 앗아가고 있다.
세계 말라리아의 날은 4월 25일에 기념되며, 예방 가능하지만 치명적일 수 있는 모기 매개 질병 박멸을 위한 글로벌 노력을 강조한다. 올해의 주제는 '말라리아 종식을 위해 주도하자: 이제 우리는 할 수 있다. 이제 우리는 해야 한다'이며, 글로벌 보건 커뮤니티가 촉구되고 있다.
아프리카질병통제예방센터(Africa CDC)는 신생아와 체중 5킬로그램 미만의 영아를 위해 설계된 첫 번째 말라리아 치료제 승인을 환영하며, 이를 "주요한 진전"이라고 칭했다.
한 국가는 약 10년간 말라리아 감염이 감소했으며, 감염 사례가 2016년 거의 500만 건에서 2023년 43만 건으로 떨어졌다 - 90% 감소. 그러나 2024년에는 말라리아 사례가 45% 이상 증가했으며, 이로 인해 보건 당국은 2020년 WHO와 GAVI의 1차 배포 단계에서 말라리아 백신 수령을 거부하기로 한 이전 결정을 재고하도록 촉구받았다.
테드로스 아다놈 게브레예수스 WHO 사무총장은 질병 퇴치 과정에서 이루어진 진전을 찬양했다: "수세기 동안 말라리아는 부모들로부터 자녀들을 빼앗았으며, 지역사회로부터 건강, 부, 희망을 앗아갔다". WHO 사무총장은 새로운 백신, 진단 검사, 차세대 모기장도 상황을 반전시키는 데 도움이 되고 있다고 덧붙였다.
새로운 아르테메터-루메팬트린 제제는 PAMAfrica 컨소시엄 산하에서 노바티스와 말라리아약물벤처(MMV) 간의 파트너십을 통해 개발되었다. 2025년 8월, 아프리카질병통제예방센터(Africa CDC)는 스위스 의약품 규제기관의 제제 승인을 칭찬하면서 임상시험에 참여한 8개 아프리카 국가를 칭송했다.
예방 가능한 도구에도 불구하고 아프리카에서는 감염 사례가 증가하고 있으며, 2030년 유엔 소멸 목표 달성을 위한 긴급한 글로벌 촉구가 이루어지고 있다. 말라리아는 전 세계적으로 계속해서 수천 명의 생명을 앗아가고 있다.
세계 말라리아의 날은 4월 25일에 기념되며, 예방 가능하지만 치명적일 수 있는 모기 매개 질병 박멸을 위한 글로벌 노력을 강조한다. 올해의 주제는 '말라리아 종식을 위해 주도하자: 이제 우리는 할 수 있다. 이제 우리는 해야 한다'이며, 글로벌 보건 커뮤니티가 촉구되고 있다.
아프리카질병통제예방센터(Africa CDC)는 신생아와 체중 5킬로그램 미만의 영아를 위해 설계된 첫 번째 말라리아 치료제 승인을 환영하며, 이를 "주요한 진전"이라고 칭했다.
한 국가는 약 10년간 말라리아 감염이 감소했으며, 감염 사례가 2016년 거의 500만 건에서 2023년 43만 건으로 떨어졌다 - 90% 감소. 그러나 2024년에는 말라리아 사례가 45% 이상 증가했으며, 이로 인해 보건 당국은 2020년 WHO와 GAVI의 1차 배포 단계에서 말라리아 백신 수령을 거부하기로 한 이전 결정을 재고하도록 촉구받았다.
처리 완료
2,674 tokens · $0.0062
기사 수집 완료 · 22:50
매체 피드에서 기사 메타데이터 수집
헤드라인 번역 완료 · 23:05
제목/요약 한국어 번역 (fetch 시점 inline)
claude-haiku-4-5-20251001
149 tokens
$0.00039
1.5s
본문 추출 완료
4,244자 추출 완료
본문 한국어 번역 완료 · 23:05
1,044자 번역 완료
claude-haiku-4-5-20251001
2,525 tokens
$0.00581
17.4s
지정학적 엔티티 추출 완료 · 23:05
4개 엔티티 추출 완료
지정학적 맥락 & R-Scanner
R-Scanner · 핫스팟
z=1.93
평소보다 훨씬 많은 매체가 집중 보도 중 — 기준: Africa
(🇿🇦 ZA)
최근 6시간 6건
7일 평균 2.43건 / 6h
2개국 매체
3개 매체
본문에서 추출된 지명 (4)
위치 지도
지도 로딩 중…
같은 주제의 다른 기사 (최근 7일)
The World Health Organization (WHO) has approved the first malaria treatment developed exclusively for newborns and very young infants. The approval, announced on April 24, confirms that the treatment meets international standards for safety and effectiveness.
WHO Director-General Dr. Tedros Adhanom Ghebreyesus hailed the progress being made in the fight against the disease: "For centuries, malaria has stolen children from their parents, and health, wealth, and hope from communities". The WHO chief added that new vaccines, diagnostic tests, and next-generation mosquito nets are also helping to turn the tide.
The new artemether-lumefantrine formulation was developed through a partnership between Novartis and the Medicines for Malaria Venture (MMV), under the PAMAfrica consortium. In August 2025, the Africa Centres for Disease Control and Prevention (Africa CDC) praised the Swiss drug regulator's approval of the formulation while commending eight African countries for their participation in clinical trials.
Africa:
First Malaria Drug for Newborns Gets WHO Approval
The World Health Organization (WHO has approved the first malaria treatment made for newborns and very young infants, in an effort to improve care for children most at risk. Read more »
Africa:
Africa CDC Applauds First-Ever Malaria Treatment for Infants Under 5 Kg
New infant-friendly formulation closes a critical treatment gap for the youngest children, with support from African-led trials and global partners. Read more »
Africa:
Progress in Reducing Child Deaths Slows As 4.9 Million Children Die Before Age Five
An estimated 4.9 million children died before their fifth birthday in 2024, including 2.3 million newborns, according to new estimates released today. Most of these deaths are… Read more »
Africa:
Nigeria Joins Africa in Breakthrough Malaria Treatment for Newborns
The Africa Centres for Disease Control and Prevention (Africa CDC) applauded Nigeria for its role in the trials in a statement on Sunday. Read more »
Despite preventable tools, cases are rising in Africa, prompting a global call to meet the UN's 2030 elimination goal with increased urgency. Malaria continues to claim the lives of thousands of people worldwide.
World Malaria Day is observed on April 25, highlighting the global fight to eradicate a mosquito-borne disease that is preventable but can be deadly. This year's theme is 'Driven to End Malaria: Now We Can. Now We Must', the global health community is being called
Join us as we continue our in-depth series where we'll share the groundbreaking Malaria Consortium research about how malaria and Covid-19 intersect, and the high prevalence of this debilitating new condition called Long Covid.
This week allAfrica's Melody Chironda and Juanita Williams continue their conversation with Dr Jane
The Africa Centres for Disease Control and Prevention (Africa CDC) has welcomed the approval of the first malaria treatment designed for newborns and infants under five kilograms, calling it a "major step forward".
The new artemether-lumefantrin formulation for children was developed through a partnership between Novartis and
The country saw a decline in malaria infections for about a decade, with cases falling from nearly five million in 2016, to 430,000 in 2023 -- a 90% reduction. In 2024, however, malaria cases rose by more than 45%, prompting health authorities to reconsider an earlier decision to opt out of receiving malaria vaccines during the first phase of distribution by the World Health Organization and GAVI in 202
New mothers in a Lilongwe hospital (file photo).
AllAfrica publishes around 600 reports a day from more than 90 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.
Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.
WHO Director-General Dr. Tedros Adhanom Ghebreyesus hailed the progress being made in the fight against the disease: "For centuries, malaria has stolen children from their parents, and health, wealth, and hope from communities". The WHO chief added that new vaccines, diagnostic tests, and next-generation mosquito nets are also helping to turn the tide.
The new artemether-lumefantrine formulation was developed through a partnership between Novartis and the Medicines for Malaria Venture (MMV), under the PAMAfrica consortium. In August 2025, the Africa Centres for Disease Control and Prevention (Africa CDC) praised the Swiss drug regulator's approval of the formulation while commending eight African countries for their participation in clinical trials.
Africa:
First Malaria Drug for Newborns Gets WHO Approval
The World Health Organization (WHO has approved the first malaria treatment made for newborns and very young infants, in an effort to improve care for children most at risk. Read more »
Africa:
Africa CDC Applauds First-Ever Malaria Treatment for Infants Under 5 Kg
New infant-friendly formulation closes a critical treatment gap for the youngest children, with support from African-led trials and global partners. Read more »
Africa:
Progress in Reducing Child Deaths Slows As 4.9 Million Children Die Before Age Five
An estimated 4.9 million children died before their fifth birthday in 2024, including 2.3 million newborns, according to new estimates released today. Most of these deaths are… Read more »
Africa:
Nigeria Joins Africa in Breakthrough Malaria Treatment for Newborns
The Africa Centres for Disease Control and Prevention (Africa CDC) applauded Nigeria for its role in the trials in a statement on Sunday. Read more »
Despite preventable tools, cases are rising in Africa, prompting a global call to meet the UN's 2030 elimination goal with increased urgency. Malaria continues to claim the lives of thousands of people worldwide.
World Malaria Day is observed on April 25, highlighting the global fight to eradicate a mosquito-borne disease that is preventable but can be deadly. This year's theme is 'Driven to End Malaria: Now We Can. Now We Must', the global health community is being called
Join us as we continue our in-depth series where we'll share the groundbreaking Malaria Consortium research about how malaria and Covid-19 intersect, and the high prevalence of this debilitating new condition called Long Covid.
This week allAfrica's Melody Chironda and Juanita Williams continue their conversation with Dr Jane
The Africa Centres for Disease Control and Prevention (Africa CDC) has welcomed the approval of the first malaria treatment designed for newborns and infants under five kilograms, calling it a "major step forward".
The new artemether-lumefantrin formulation for children was developed through a partnership between Novartis and
The country saw a decline in malaria infections for about a decade, with cases falling from nearly five million in 2016, to 430,000 in 2023 -- a 90% reduction. In 2024, however, malaria cases rose by more than 45%, prompting health authorities to reconsider an earlier decision to opt out of receiving malaria vaccines during the first phase of distribution by the World Health Organization and GAVI in 202
New mothers in a Lilongwe hospital (file photo).
AllAfrica publishes around 600 reports a day from more than 90 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.
Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.